Chlamydia pneumoniae pneumonia

Seminars in Respiratory and Critical Care Medicine

Volumn 21, Issue 4, 2000, Pages 285-294

  File T M , Jr ^a   Tan, J S ^a  

^a NONE   (United States)

Author keywords

Chlamydia pneumoniae; Fluoroquinolines; Macrolides; Pneumonia; Tetracyclines

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; DIRITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; SPARFLOXACIN; TETRACYCLINE; UNCLASSIFIED DRUG; XAGAM;

ADULT; AGED; ANTIBIOTIC THERAPY; ANTIBODY TITER; ASTHMA; BACTERIAL PNEUMONIA; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; INCIDENCE; INTENSIVE CARE; MALE; OPPORTUNISTIC INFECTION; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW;

EID: 0033841672     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-9857     Document Type: Review

References (61)

1. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infection
2. Chlamydia pneumoniae (TWAR)
3. Pathogenetic mechanisms and epidemiology, of Chlamydia pneumoniae
4. Experimental infection with Chlamydia pneumoniae in non-human primates
5. A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis
6. Animal model. Experimental rabbit models of Chlamydia pneumoniae infection
7. Animal models for Chlamydia pneumoniae infection
8. Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice
9. Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone
10. Respiratory infection with Chlamydia pneumoniae in middle-aged and older adult outpatients
11. Pneumonia due to Chlamydia pneumoniae: Prevalence, clinical features, diagnosis, and treatment
12. Ultrastructural lung pathology of experimental Chlamydia pneumoniae pneumonitis in mice
13. Chlamydia pneumoniae - A new causatime agent of reactive arthritis and undifferentiated arthritis
14. Reinfection with Chlamydia pneumoniae may induce isolated and systemic vasculitis in small and large vessels
15. The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland
16. Severe community-acquired pneumonia: A possible role for Chlamydia pneumoniae
17. Chlamydia pneumoniae as a new source of infectious outbreaks in nursing homes
18. Preliminary findings of a community-based pneumonia incidence study
19. Incidence of community- acquired pneumonia and Chlamydia pneumoniae infection: A prospective multi-centre study
20. Chlamydia pneumoniae. Defining the clinical spectrum of infection requires precise laboratory diagnosis
21. The importance of Chlamydia pneumoniae as a pathogen: The 1996 consensus conference on Chlamydia pneumoniae infections
22. A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity
23. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis
24. Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae during an epidemic in Finland
25. Diagnostic methods for intracellular pathogens
26. Age related interferences with Chlamydai pneumoniae microimmunofluorescence serology due to circulating rheumatoid factor
27. Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults
28. Community-acquired pneumonia due to atypical organisms in adults: Diagnosis and treatment
29. Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients
30. Replication of Chlamydia pneumoniae in vitro human macrophages, endothelial cells, and aortic artery smooth muscle cells
31. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases
32. Pneumonia associated with the TWAR strain of Chlamydia
33. Infection with Chlamydia pneumoniae in Brooklyn
34. Asymptomatic respiratory tract infection with Chlamydia pneumoniae TWAR
35. Clinical characteristics of Chlamydia pneumoniae infection as the sole cause of community-acquired pneumonia
36. Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: A comparison between chlamydial and pneumococcal pneumonia
37. Community- and hospital-acquired pneumonia associated with Chlamydia TWAR infection demonstrated serologically
38. Radiographic appearance of Chlamydia pneumoniae (TWAR strain) respiratory infections
39. An epidemic of infections due to Chlamydia pneumoniae in military conscripts
40. Chlamydia pneumoniae, strain TWAR, infection in patients with chronic obstructive pulmonary disease
41. The association of Chlamydia pneumoniae infection and reactive airway disease in children
42. The role of Chlamydia pneumoniae in atherosclerosis
43. Elevated Chlamydia pneumoniae antibodies cardiovascular events, and azithromycin in male survivors of myocardial infarction
44. Chronic infections and coronary heart disease: Is there a link?
45. Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae
46. Incidence of community-acquired pneumonia caused by Chlamydia pneumoniae in Italian patients
47. Comparative safety and efficacy of clarithromycin and erythromycin ethylsuccinate suspensions in the treatment of children with community acquired pneumonia
48. Persistent infection with Chlamydia pneumoniae following acute respiratory illness
49. A multicenter randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin verses ceftriaxone and/or cefuroxime axetil in the treatment of adults with community-acquired pneumonia
50. Community-acquired pneumonia: Impact of immune status
51. Etiology of community-acquired pneumonia in hospitalized patients: A 3-year prospective study in Japan
52. Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia
53. Efficacy of clarithromycin against Mycoplasma pneumoniae
54. The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae and Legionella pneumophila in respiratory infection